Karyopharm Therapeutics Inc.
KPTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001503802
In the last 90 days, Karyopharm Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $206.8M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Karyopharm Therapeutics Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 171 | 1 | 154 | −16 |
| Shares | 60.2M | 11.3K | 59.0M | −1.17M (−1.9%) |
| Value | $637.1M | $118.0K | $608.7M | −$28.3M (−4.4%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Karyopharm Therapeutics Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rubric Capital Management LP | 4,253,212 | $43.9M | 2.77% |
| Jacobs Levy Equity Management, Inc | 81,257 | $839.0K | 0.01% |
| M&G Investment Management Ltd | 62,183 | $622.0K | 0.00% |
| Algert Global LLC | 36,320 | $375.0K | 0.13% |
| Squarepoint Ops LLC | 34,409 | $355.0K | 0.00% |
| Virginia Retirement Systems Et Al | 23,500 | $243.0K | 0.00% |
| Boothbay Fund Management, LLC | 23,067 | $238.0K | 0.01% |
| Centiva Capital, LP | 20,405 | $211.0K | 0.02% |
| Renaissance Technologies LLC | 18,472 | $191.0K | 0.00% |
| State of Wyoming | 14,403 | $149.0K | 0.09% |
| ACT Capital Management, LLC | 14,000 | $145.0K | 0.07% |
| LPL Financial LLC | 10,558 | $109.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,431 | $108.0K | 0.00% |
| Altshuler Shaham Ltd | 9,739 | $101.0K | 0.00% |
| Tarbox Family Office, Inc. | 3,000 | $31.0K | 0.01% |
| American Portfolios Advisors | 1,000 | $10.3K | 0.00% |
| Founders Capital Management | 1,000 | $10.0K | 0.01% |
| Advisory Services Network, LLC | 900 | $9.00K | 0.00% |
| Lindbrook Capital, LLC | 575 | $6.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 298 | $3.00K | 0.00% |
| Quadrant Capital Group LLC | 25 | $0 | 0.00% |
Sold out (37)
Institutions that held Karyopharm Therapeutics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (1)
Institutions that held Karyopharm Therapeutics Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| E Fund Management Co., Ltd. | 11,264 | $118.0K |